The End Is Nigh For Mylan, But How Different Will The New Company Be?

Mylan will be merged into a new company with Pfizer’s Upjohn, closing the chapter on a generic drug powerhouse that will be remembered as much for scandal as success.

The End handwrite title on red round background. Old movie circle ending screen. Vector illustration - Vector

Mylan NV has a long history in the generic pharmaceutical market, maintaining its independence while plenty of other mid-sized specialty generic peers were absorbed into larger corporations. Now the Mylan story draws to an end with the company's planned merger with Pfizer Inc.'s off patent Upjohn business and the creation of a new company.

Mylan's evolution into one of the top generic drug companies in the world has been a roller coaster of highs...